EP0736007A4 - Non-peptide tachykinin receptor antagonists - Google Patents
Non-peptide tachykinin receptor antagonistsInfo
- Publication number
- EP0736007A4 EP0736007A4 EP95904891A EP95904891A EP0736007A4 EP 0736007 A4 EP0736007 A4 EP 0736007A4 EP 95904891 A EP95904891 A EP 95904891A EP 95904891 A EP95904891 A EP 95904891A EP 0736007 A4 EP0736007 A4 EP 0736007A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- receptor antagonists
- tachykinin receptor
- peptide tachykinin
- peptide
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17113493A | 1993-12-21 | 1993-12-21 | |
US171134 | 1993-12-21 | ||
PCT/US1994/014312 WO1995017382A1 (en) | 1993-12-21 | 1994-12-14 | Non-peptide tachykinin receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0736007A1 EP0736007A1 (en) | 1996-10-09 |
EP0736007A4 true EP0736007A4 (en) | 1997-03-19 |
Family
ID=22622667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95904891A Withdrawn EP0736007A4 (en) | 1993-12-21 | 1994-12-14 | Non-peptide tachykinin receptor antagonists |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0736007A4 (en) |
JP (1) | JPH09506898A (en) |
AU (1) | AU1339795A (en) |
CA (1) | CA2176130A1 (en) |
MX (1) | MXPA99001870A (en) |
WO (1) | WO1995017382A1 (en) |
ZA (1) | ZA9410040B (en) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5492927A (en) * | 1993-12-21 | 1996-02-20 | Eli Lilly And Company | Non-peptide tachykinin receptor antagonists to treat allergy |
EP0735821A4 (en) * | 1993-12-21 | 1998-04-01 | Lilly Co Eli | Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
IL115582A0 (en) * | 1994-10-14 | 1996-01-19 | Lilly Co Eli | Methods for treating resistant tumors |
IL115613A0 (en) * | 1994-10-20 | 1996-01-19 | Lilly Co Eli | Bicyclic neuropeptide y receptor antagonists |
WO1996012488A1 (en) * | 1994-10-20 | 1996-05-02 | Eli Lilly And Company | Bicyclic bradykinin receptor antagonists |
EP2266560A1 (en) * | 1996-03-26 | 2010-12-29 | Eli Lilly & Company | Benzothiophenes, formulations containing same, and methods |
US6458811B1 (en) | 1996-03-26 | 2002-10-01 | Eli Lilly And Company | Benzothiophenes formulations containing same and methods |
CA2206752A1 (en) | 1996-07-02 | 1998-01-02 | George Joseph Cullinan | Benzothiophene compounds, intermediates, processes, and methods of use |
AU7274098A (en) | 1997-04-30 | 1998-11-24 | Eli Lilly And Company | Antithrombotic agents |
AU7170898A (en) | 1997-04-30 | 1998-11-24 | Eli Lilly And Company | Antithrombotic agents |
JP2001522373A (en) | 1997-04-30 | 2001-11-13 | イーライ・リリー・アンド・カンパニー | Antithrombotic agent |
ATE286395T1 (en) | 1997-04-30 | 2005-01-15 | Lilly Co Eli | ANTITHRBOTIC AGENTS |
US6284756B1 (en) | 1998-04-30 | 2001-09-04 | Eli Lilly And Company | Antithrombotic agents |
EP0997460B1 (en) * | 1998-10-28 | 2002-12-11 | Eli Lilly And Company | Benzothiophene compounds as antithrombotic agents and intermediates |
US7056931B2 (en) | 2001-05-22 | 2006-06-06 | Eli Lilly And Company | 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
EP1401446B1 (en) | 2001-05-22 | 2005-02-09 | Eli Lilly And Company | Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
GB0130305D0 (en) * | 2001-12-19 | 2002-02-06 | Amersham Plc | Compounds for imaging alzheimers disease |
CA2573271C (en) | 2004-07-15 | 2015-10-06 | Amr Technology, Inc. | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
WO2006123182A2 (en) | 2005-05-17 | 2006-11-23 | Merck Sharp & Dohme Limited | Cyclohexyl sulphones for treatment of cancer |
BRPI0613403A2 (en) | 2005-07-15 | 2009-02-10 | Amr Technology Inc | aryl and heteroaryl substituted tetrahydrobenzodiazepines and their use to block reuptake of norepinephrine, dopamine and serotonin |
JP4879988B2 (en) | 2005-09-29 | 2012-02-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
EP2083831B1 (en) | 2006-09-22 | 2013-12-25 | Merck Sharp & Dohme Corp. | Method of treatment using fatty acid synthesis inhibitors |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
EP2336120B1 (en) | 2007-01-10 | 2014-07-16 | MSD Italia S.r.l. | Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
EP2145884B1 (en) | 2007-04-02 | 2014-08-06 | Msd K.K. | Indoledione derivative |
US8389553B2 (en) | 2007-06-27 | 2013-03-05 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
US8598184B2 (en) | 2008-03-03 | 2013-12-03 | Tiger Pharmatech | Protein kinase inhibitors |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
JP5739415B2 (en) | 2009-05-12 | 2015-06-24 | ブリストル−マイヤーズ スクウィブ カンパニー | (S) -7-([1,2,4] triazolo [1,5-a] pyridin-6-yl) -4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydroisoquinoline Crystal forms and uses thereof |
EP2429295B1 (en) | 2009-05-12 | 2013-12-25 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
ES2662072T3 (en) | 2009-05-12 | 2018-04-05 | Albany Molecular Research, Inc. | 7 - ([1,2,4] triazolo [1,5-a] pyridin-6-yl) -4- (3,4-dichlorophenyl) -1,2,3,4-tetrahydroisoquinoline and use thereof |
KR101485645B1 (en) | 2009-10-14 | 2015-01-22 | 머크 샤프 앤드 돔 코포레이션 | SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF |
US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
CN107090456B (en) | 2010-08-02 | 2022-01-18 | 瑟纳治疗公司 | Inhibition of beta 1 gene expression using short interfering nucleic acids mediated by RNA interference of catenin (cadherin-associated protein) |
EP4079856A1 (en) | 2010-08-17 | 2022-10-26 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
EP2615916B1 (en) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel erk inhibitors |
WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
EP2654748B1 (en) | 2010-12-21 | 2016-07-27 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
US20140045847A1 (en) | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation |
EP2770987B1 (en) | 2011-10-27 | 2018-04-04 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
EP2844261B1 (en) | 2012-05-02 | 2018-10-17 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
EP2900241B1 (en) | 2012-09-28 | 2018-08-08 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
SI2925888T1 (en) | 2012-11-28 | 2018-02-28 | Merck Sharp & Dohme Corp. | Compositions and methods for treating cancer |
RU2690663C2 (en) | 2012-12-20 | 2019-06-05 | Мерк Шарп И Доум Корп. | Substituted imidazopyridines as hdm2 inhibitors |
US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
EP3833668A4 (en) | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
US11981701B2 (en) | 2018-08-07 | 2024-05-14 | Merck Sharp & Dohme Llc | PRMT5 inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024273A (en) * | 1974-06-20 | 1977-05-17 | Smithkline Corporation | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1300575B (en) * | 1965-05-21 | 1969-08-07 | Bristol Myers Co | Benzo [b] thiophenes |
US3880891A (en) * | 1973-09-21 | 1975-04-29 | Smithkline Corp | Substituted benzofurans |
US3975537A (en) * | 1973-09-21 | 1976-08-17 | Smith Kline | Pharmaceutical compositions and methods of producing coronary vasodilation |
US3947470A (en) * | 1974-06-20 | 1976-03-30 | Smithkline Corporation | Substituted benzofurans and benzothiophenes |
US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
US4230862A (en) * | 1975-10-28 | 1980-10-28 | Eli Lilly And Company | Antifertility compounds |
US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
-
1994
- 1994-12-14 AU AU13397/95A patent/AU1339795A/en not_active Abandoned
- 1994-12-14 JP JP7517478A patent/JPH09506898A/en active Pending
- 1994-12-14 EP EP95904891A patent/EP0736007A4/en not_active Withdrawn
- 1994-12-14 WO PCT/US1994/014312 patent/WO1995017382A1/en not_active Application Discontinuation
- 1994-12-14 CA CA002176130A patent/CA2176130A1/en not_active Abandoned
- 1994-12-15 ZA ZA9410040A patent/ZA9410040B/en unknown
-
1999
- 1999-02-25 MX MXPA99001870A patent/MXPA99001870A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024273A (en) * | 1974-06-20 | 1977-05-17 | Smithkline Corporation | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity |
Non-Patent Citations (11)
Title |
---|
CHEMICAL ABSTRACTS, vol. 105, no. 5, 4 August 1986, Columbus, Ohio, US; abstract no. 42591k, HUANG, WENLONG ET AL: "Synthesis of ..." XP002023027 * |
CHEMICAL ABSTRACTS, vol. 106, no. 9, 2 March 1987, Columbus, Ohio, US; abstract no. 60767x, DAI,DEZAI ET AL.: "Anticonvulsant and analgesic activities of ..." XP002023026 * |
CHEMICAL ABSTRACTS, vol. 111, no. 7, 14 August 1989, Columbus, Ohio, US; abstract no. 57444n, DUNARI, NEELAM ET AL: "Structure-activity relationship of antiestrogens. ..." XP002023025 * |
CHEMICAL ABSTRACTS, vol. 88, no. 3, 16 January 1978, Columbus, Ohio, US; abstract no. 22527w, INION, HENRI ET AL: "Study of the indole series. IV. ..." XP002023028 * |
CHEMICAL ABSTRACTS, vol. 99, no. 19, 7 November 1983, Columbus, Ohio, US; abstract no. 158165m, DURANI, N. ET AL: "A convenient synthesis of ..." XP002023029 * |
EUR. J. MED. CHEM. - CHIM. THER., vol. 12, no. 5, - 1977, pages 483 - 487 * |
INDIAN J. CHEM., SECT. B, vol. 22b, no. 5, - 1983, pages 489 - 490 * |
J. MED. CHEM., vol. 32, no. 8, - 1989, pages 1700 - 1707 * |
NANJING YAOXUEYUAN XUEBAO, vol. 17, no. 3, - 1986, pages 225 - 228 * |
See also references of WO9517382A1 * |
YAOXUE XUEBAO, vol. 20, no. 10, - 1985, pages 737 - 746 * |
Also Published As
Publication number | Publication date |
---|---|
CA2176130A1 (en) | 1995-06-29 |
JPH09506898A (en) | 1997-07-08 |
WO1995017382A1 (en) | 1995-06-29 |
MXPA99001870A (en) | 2004-09-06 |
EP0736007A1 (en) | 1996-10-09 |
ZA9410040B (en) | 1996-06-18 |
AU1339795A (en) | 1995-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9410040B (en) | Non-peptide tachykinin receptor antagonists | |
HU9403676D0 (en) | Non-peptide tachykinin receptor antagonists | |
EP0819005A4 (en) | 2-acylaminopropanamides as tachykinin receptor antagonists | |
HU9501249D0 (en) | Non-peptidyl tachykinin receptor antagonists | |
ZA948541B (en) | Endothelin receptor antagonists | |
EP0858444A4 (en) | Cyclopentyl tachykinin receptor antagonists | |
GB9405317D0 (en) | Fibrinogen receptor antagonists | |
HU9603525D0 (en) | Vironectin receptor antagonists | |
HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
EP0810994A4 (en) | Fibrinogen receptor antagonists | |
EP0912175A4 (en) | Fibrinogen receptor antagonists | |
EP0866705A4 (en) | Fibrinogen receptor antagonists | |
HU9403469D0 (en) | Excitatory receptor antagonists | |
SG49667A1 (en) | Endothelin receptor antagonists | |
EP0885205A4 (en) | Fibrinogen receptor antagonists | |
EP0885213A4 (en) | Fibrinogen receptor antagonists | |
HU9502028D0 (en) | Fibrinogen receptor antagonists | |
EP0805681A4 (en) | Tocolytic oxytocin receptor antagonists | |
IL134301A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
ZA98256B (en) | Tachykinin antagonists | |
NO179550C (en) | Tachykinin receptor antagonists | |
GB9320799D0 (en) | Fibrinogen receptor antagonists | |
IL134155A0 (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
AU7856194A (en) | N-benzoyl-4-oxy/thio-2-substituted piperidines as substance-p receptor antagonists | |
GB9420262D0 (en) | Tryptophan esters as tachykinin receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960621 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: LT PAYMENT 960621;SI PAYMENT 960621 |
|
RAX | Requested extension states of the european patent have changed |
Free format text: LT PAYMENT 960621;SI PAYMENT 960621 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19970204 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19981221 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19990701 |